Factors associated with severe pain during medication abortion at ≤9 weeks' gestation: A secondary analysis of a multicenter, randomized, placebo-controlled trial.

Contraception Pub Date : 2025-02-27 DOI:10.1016/j.contraception.2025.110859

Kelsey B Loeliger, Monica V Dragoman, Nathalie Kapp, Anand Tamang, Tshegofatso Bessenaar, Duong Lan Dung, Jageshwor Gautam, Jean-Louis Yoko, Nguyen Hong Minh, Daniel Grossman

{"title":"Factors associated with severe pain during medication abortion at ≤9 weeks' gestation: A secondary analysis of a multicenter, randomized, placebo-controlled trial.","authors":"Kelsey B Loeliger, Monica V Dragoman, Nathalie Kapp, Anand Tamang, Tshegofatso Bessenaar, Duong Lan Dung, Jageshwor Gautam, Jean-Louis Yoko, Nguyen Hong Minh, Daniel Grossman","doi":"10.1016/j.contraception.2025.110859","DOIUrl":null,"url":null,"abstract":"Objective: To identify covariates other than pain management regimen associated with severe pain during medication abortion at ≤9 weeks' gestation.Study design: This is a secondary analysis of a randomized trial in Vietnam, Nepal, and South Africa investigating two prophylactic pain management regimens during medication abortion. We used multivariable logistic regression models to identify factors associated with severe pain within 8 hours after taking misoprostol.Results: During June 2016-October 2017, 273 of 556 (49.1%) participants experienced severe pain (score >8 out of 10). In multivariable analyses, controlling for study center and prophylactic treatment arm, multiparity (OR 0.35, 95% CI 0.23-0.53) was associated with reduced odds of severe pain while dysmenorrhea (OR 1.16, 95% CI 1.07-1.26) and higher gestational duration (OR 1.05, 95% CI 1.01-1.09) were associated with increased odds of pain. Higher anticipated pain score (OR 1.10, 95% CI 0.99-1.23) was marginally associated with severe pain. Among multiparous patients, history of cesarean delivery (OR 3.49, 95% CI 1.24-9.77), severe pain in childbirth (OR 2.36, 95% CI 1.03-5.42), and dysmenorrhea (OR 1.22, 95% CI 1.08-1.39) were significantly associated with severe pain. Higher gestational duration (OR 1.05, 95% CI 0.99-1.11) trended toward an association with severe pain. Sociodemographic variables including younger age, marital status, financial stability, and anxiety or depression were not associated with pain.Conclusions: Beyond known risk factors of parity, dysmenorrhea, and gestational duration, this analysis demonstrates that severe pain during medication abortion is significantly associated with history of cesarean delivery and severe pain in childbirth. Depression and anxiety were not associated with severe pain. These findings can inform counseling for patients seeking medication abortion.Clinical trial registration number: ACTRN126130 0 0 017729.","PeriodicalId":93955,"journal":{"name":"Contraception","volume":" ","pages":"110859"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contraception","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.contraception.2025.110859","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: To identify covariates other than pain management regimen associated with severe pain during medication abortion at ≤9 weeks' gestation.

Study design: This is a secondary analysis of a randomized trial in Vietnam, Nepal, and South Africa investigating two prophylactic pain management regimens during medication abortion. We used multivariable logistic regression models to identify factors associated with severe pain within 8 hours after taking misoprostol.

Results: During June 2016-October 2017, 273 of 556 (49.1%) participants experienced severe pain (score >8 out of 10). In multivariable analyses, controlling for study center and prophylactic treatment arm, multiparity (OR 0.35, 95% CI 0.23-0.53) was associated with reduced odds of severe pain while dysmenorrhea (OR 1.16, 95% CI 1.07-1.26) and higher gestational duration (OR 1.05, 95% CI 1.01-1.09) were associated with increased odds of pain. Higher anticipated pain score (OR 1.10, 95% CI 0.99-1.23) was marginally associated with severe pain. Among multiparous patients, history of cesarean delivery (OR 3.49, 95% CI 1.24-9.77), severe pain in childbirth (OR 2.36, 95% CI 1.03-5.42), and dysmenorrhea (OR 1.22, 95% CI 1.08-1.39) were significantly associated with severe pain. Higher gestational duration (OR 1.05, 95% CI 0.99-1.11) trended toward an association with severe pain. Sociodemographic variables including younger age, marital status, financial stability, and anxiety or depression were not associated with pain.

Conclusions: Beyond known risk factors of parity, dysmenorrhea, and gestational duration, this analysis demonstrates that severe pain during medication abortion is significantly associated with history of cesarean delivery and severe pain in childbirth. Depression and anxiety were not associated with severe pain. These findings can inform counseling for patients seeking medication abortion.

Clinical trial registration number: ACTRN126130 0 0 017729.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Contraception

自引率

0.00%

发文量